Stock Events

Alphatec 

€5.1
21
+€0+0% Hoje

Estatísticas

Ponto mais alto do dia
5.1
Ponto mais baixo do dia
5.1
Ponto mais alto em 52 semanas
-
Ponto mais baixo em 52 semanas
-
Volume
0
Volume méd.
-
Limite da capitalização de mercado
708.78M
Rácio PER
-
Rendimento de dividendos
-
Dividendo
-

Em breve

Rendimentos

31OctEsperado
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Seguinte
-0.43
-0.31
-0.19
-0.07
Resultados por ação esperados
-0.10625
Resultados por ação reais
N/D

As pessoas também seguem

Esta lista baseia-se nas listas de observação de pessoas na Stock Events que seguem L1Z1.F. Não é uma recomendação de investimento.

Concorrentes

Esta lista é uma análise baseada em eventos recentes do mercado. Não é uma recomendação de investimento.

Sobre

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Show more...
CEO
Mr. Patrick S. Miles
Funcionários
839
País
US
ISIN
US02081G2012
WKN
000A2AP5V

Listagens